Showing results (61-70 of 152) with videos related to
Sort By:
Pageof 16
Plos One|June 3, 2008
L-type Ca2+ channel function is linked to dystrophin expression in mammalian muscleOliver Friedrich, Frederic von Wegner, Jeffrey S Chamberlain, et al.JCI Insight|November 27, 2025
Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscleErynn E Johnson, Theodore R Reyes, Jeffrey S Chamberlain, et al.Muscle & Nerve|August 11, 2007
Fluorophore-labeled myosin-specific antibodies simplify muscle-fiber phenotypingPaul Gregorevic, Norman A Meznarich, Michael J Blankinship, et al.Human Molecular Genetics|June 26, 2007
Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domainGlen B Banks, Paul Gregorevic, James M Allen, et al.Current Gene Therapy|April 27, 2012
Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectorsJane T Seto, Julian N Ramos, Lindsey Muir, et al.Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|December 12, 2018
High Resource Utilization of Psychiatric Emergency Services by Methamphetamine UsersBrian R Schultz, Brett Y Lu, Jane M Onoye, et al.Human Molecular Genetics|October 10, 2015
Progress and prospects of gene therapy clinical trials for the muscular dystrophiesNiclas E Bengtsson, Jane T Seto, John K Hall, et al.Circulation|September 4, 2003
Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heartYongping Yue, Zhenbo Li, Scott Q Harper, et al.Plos One|October 27, 2018
Non-invasive tracking of disease progression in young dystrophic muscles using multi-parametric MRI at 14TJoshua S Park, Ravneet Vohra, Thomas Klussmann, et al.Plos One|October 15, 2008
Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout miceJustin M Percival, Kendra N E Anderson, Paul Gregorevic, et al.Pageof 16